Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL) - No Study Results Posted

Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL) (LUCID)

This study is currently recruiting participants.

Study NCT00391066 Information provided by Biogen Idec

First Received: October 19, 2006 Last Updated: September 25, 2009 History of Changes

No Study Results Posted for this Study

About Study Results Reporting

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	December 2014
Estimated Primary Completion Date:	May 2014 (Final data collection date for primary outcome measure)